To check the effect of Plum Vitamin C serum for skin brightening.

Not Applicable

Recruiting

Brief Summary: Each participant entering the trial will be assigned to a regimen of investigational product, and advised to take general precautions as needed.Patients will be assigned to this study for 28 days in which Day 0 (Visit 1/Screening) done for screening purpose and handover the IP to the Subjects, and measure Melanin content by Mexameter, skin analysis by Spectrophotometer, Imagination of Dermis/ Epidermis, take HD picture by DSLR and Visio face scan/DJM scan. Additional on Day 14 or Visit 2 is required for doing subject assessment in which determination of the brightening of skin, dark spot intensity, tanning of skin, skin tone/texture, moisturizing level of skin and glowing of skin.Also, on the Day 14/ Visit 2 measure the physical characteristics which include texture of the test product, Spread-ability of the IP on the face and check the quickly absorption on the skin.On the Day 28/Visit 3/ Follow up, check the effect of IP by subject assessments and also any AE (Itching, Irritation and Burning sensation of the affected skin)

Recruitment & Eligibility

Inclusion Criteria

Gender: Non-pregnant, non-lactating female aged between 18 to 34 2.
Subject willing to give written informed consent 3.
Women of child bearing potential must have a negative urine pregnancy test 4.
Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.
Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

Exclusion Criteria

Subjects who are pregnant, breast feeding, or planning to become pregnant during the study 2.
Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition.
Have open sore or open lesions in the treatment area 4.
Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
Have participated in any interventional clinical trial in the previous 30 days.
6.Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents.
Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids.
Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Primary Outcome Measures

Name	Time	Method
1. Change in percentage of consumers achieved a visible even tone skin/texture in 30 days.	Day14, Day 28
2. Change in percentage of volunteers achieved a visibly brighter skin in 30 days.	Day14, Day 28
3. Change in percentage of volunteers achieved a glowing skin in 30 days.	Day14, Day 28
4. Change in percentage of volunteers experienced visible reduction of dark spot/ hyperpigmentation in 30 days	Day14, Day 28
5. Change in percentage of volunteers experienced how much percentage of improvement in skin tone/texture.	Day14, Day 28

Secondary Outcome Measures

Name	Time	Method
Not applicable	Not applicable

Locations (1): CCFT laboratories
🇮🇳
Meerut, UTTAR PRADESH, India
CCFT laboratories
🇮🇳Meerut, UTTAR PRADESH, India
Dr Robin Chugh
Principal investigator
7078103723
robinderm25@gmail.com